A 59-year-old man is 2 weeks post non-ST-elevation myocardial infarction treated with percutaneous coronary intervention and a drug-eluting stent. He ...

Question

A 59-year-old man is 2 weeks post non-ST-elevation myocardial infarction treated with percutaneous coronary intervention and a drug-eluting stent. He has no major bleeding risk. According to Canadian secondary prevention guidance, what is the most appropriate antiplatelet strategy?

Accepted Answer

Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor for 12 months

Answer

Aspirin 81 mg daily alone

Answer

Clopidogrel 75 mg daily alone

Answer

Dual antiplatelet therapy with aspirin and clopidogrel for 1 month only

Answer

Triple therapy with aspirin, clopidogrel and an oral anticoagulant for 12 months

ca-mccqe1 MCQ (SBA): Secondary prevention after NSTEMI

A 59-year-old man is 2 weeks post non-ST-elevation myocardial infarction treated with percutaneous coronary intervention and a drug-eluting stent. He has no major bleeding risk. According to Canadian secondary prevention guidance, what is the most appropriate antiplatelet strategy?